Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 38Neoplasm Metastasis 16Leukemia, Myeloid, Acute 13Skin Neoplasms 10Kidney Neoplasms 10Leukemia 9Carcinoma, Renal Cell 9Neoplasms 7Ovarian Neoplasms 6Breast Neoplasms 6Lymphoma, Non-Hodgkin 5Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Congenital Abnormalities 4Neuroblastoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Recurrence 2Papillomavirus Infections 2Pancreatic Neoplasms 2Lymphoma, Mantle-Cell 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1

Interventions

Therapeutics 6Escitalopram 4Yoga 3Surveys and Questionnaires 3Sugars 2Psychiatric Rehabilitation 2Psilocybin 2Ketamine 2Vorinostat 1Ultraviolet Therapy 1Typhoid-Paratyphoid Vaccines 1Therapeutic Touch 1Temozolomide 1Self-Help Groups 1Selective Serotonin Reuptake Inhibitors 1Saline Solution 1Psychosocial Intervention 1Niacin 1Minocycline 1Methylphenidate 1Melatonin 1Massage 1Mass Screening 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Interleukin-2 1Infliximab 1Imagery, Psychotherapy 1Fatty Acids, Omega-3 1Exercise Test 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Depression × Interleukin-2 × Clear all
NCT00352885 2018-09-14

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Emory University

Phase 4 Completed
20 enrolled 11 charts

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡